Financials
Income statement
Fiscal date | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
---|---|---|---|---|
Total reported revenue | 4.8B | 6.8B | 6.0B | 6.6B |
Cost of revenue | 3.2B | 4.7B | 4.1B | 4.5B |
Gross profit | 1.6B | 2.1B | 1.9B | 2.1B |
Operating expense | ||||
Research & development | 228M | 275M | 266M | 269M |
Selling general and admin | 411M | 478M | 462M | 485M |
Other operating expenses | — | — | — | — |
Operating income | 984M | 1.3B | 1.2B | 1.4B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 394M | 404M | 346M | 323M |
Other income expense | -188M | -353M | -191M | -189M |
Pretax income | 402M | 577M | 662M | 838M |
Tax provision | 77M | 58M | 171M | 192M |
Net income | 402M | 617M | 570M | 710M |
Basic EPS | 0.3 | 0.5 | 0.4 | 0.5 |
Diluted EPS | 0.3 | 0.5 | 0.4 | 0.5 |
Basic average shares | 1.3B | 1.3B | 1.3B | 1.3B |
Diluted average shares | 1.3B | 1.3B | 1.4B | 1.4B |
EBITDA | 975M | 1.2B | 1.2B | 1.3B |
Net income from continuing op. | 402M | 617M | 570M | 710M |
Minority interests | -1M | -1M | -3M | -4M |
Preferred stock dividends | — | — | — | — |